• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA Grants 510(k) Clearance to LivaNova’s B-Capta

    Gynesonics Appoints Susan Stimson to Its Board of Directors

    Piezo Motion Debuts Piezoelectric Micro-Dosing Pump

    Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology

    Abbott Begins Shipping Rapid COVID Self-Tests
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Spectrum Plastics Group

    Qosina Corp.

    MW Life Sciences

    Concise Engineering

    Forefront Medical Technology
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EMS' Engineering Resources Increasingly in Demand

    Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

    EMS Providers Valued for Product Customization, Medical Certification Expertise

    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Unicep

    Concise Engineering

    K-Tube Technologies

    FUTEK Advanced Sensor Technology Inc.

    Medicoil
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    A Legal Eye’s View of Medtech M&A

    Richard Mattern of Bass, Berry & Sims PLC offers his insights on what can be expected in the M&A space in 2017 and beyond.

    A Legal Eye’s View of Medtech M&A
    Related CONTENT
    • Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development
    • Real-World Medical Device Hacking Tales
    • Nagarro Achieves ISO 13485 Certification
    • Mastering Motion for Robotic Surgical Systems—A Medtech Makers Q&A
    • MICRO Expands with New Facility in Costa Rica
    Sean Fenske, Editor03.30.17
    Big splashes have been made in recent years with the announcements of major mergers and acquisitions of medical device OEMs. MPO’s own Top 30 company report loses a few list members each year due to these significant transactions (making way for new entries to the list).
     
    Offering his insights on this activity is Richard F. Mattern, a member with Bass, Berry & Sims PLC. Mattern practices in the firm’s Corporate & Securities Practice Group and is based in the firm’s Memphis, Tenn. office. He works within a range of industries, but maintains a particular focus on the medical device space.
     
    Mattern took time to speak with MPO about the latest M&A activity, what he expects in 2017, and what we can look forward to in the years ahead.
     
    Sean Fenske: Can you please briefly explain your role when helping clients with M&A in the medical device industry?


    Richard F. Mattern is a member with Bass, Berry & Sims PLC.
    Richard Mattern: In short, M&A counsel runs the deal. More specifically, M&A counsel is responsible for understanding the client’s strategic objective, building and overseeing a team that can execute on that strategic objective, advising the board on its fiduciary duties, identifying risks through the diligence process, structuring the transaction to maximize benefits and minimize risks, drafting the definitive agreements, closing the transaction, and facilitating a successful integration. Each of these aspects is essential to a successful transaction and shapes nearly every decision made by M&A counsel.
     
    Fenske: We’ve seen some major activity in the M&A space in the medical device industry only to have a comparatively quieter 2016. What do you expect for the remainder of 2017?
    Mattern: For a number of reasons, I would expect 2017 to be a strong year for medical device M&A. First, the integration efforts from the 2015 M&A surge are (or should be) nearly complete. Thus, management will now have the necessary bandwidth to seek out additional opportunities. Second, certain macro-economic factors will spur additional M&A activity. Capital remains relatively accessible as interest rates remain at near historic lows, the IPO market remains choppy, significant cash is sitting on public company balance sheets, and private equity continues to invest in the sector. Similarly, the current political climate will support additional M&A activity. The Trump administration appears committed to scaling back regulation, including the potential repeal of the medical device tax, and lowering corporate tax rates.
     
    Fenske: The one exception in 2016 has been Abbott. Given the challenges they are facing, however, did they possibly move too aggressively with their M&A strategy between their St. Jude and Alere buys?
    Mattern: In 2016, Abbott struck deals with Alere (~$6B) and St. Jude Medical (~$30B). Doing a single deal of that magnitude is significant. Attempting two, especially when you layer on the challenges that came out of these deals—Alere was the subject of a DOJ probe (which has Abbott seeking to terminate the deal) and the allegations St. Jude cardiac devices were vulnerable to a potential cyber security attack—can open oneself up to criticism. However, it is premature to suggest that Abbott was too aggressive. The Abbott-St. Jude combination created a cardiovascular powerhouse, which will fortify their market position, drive revenue growth, and enhance product innovation. Furthermore, whether the Alere deal goes forward and the results of the DOJ probe will significantly shape how we judge Abbott’s 2016.
     
    Fenske: How does a company use M&A as a growth strategy? What are the advantages?
    Mattern: M&A can be an effective growth strategy. The impetus for a majority of M&A deals is generally to expand the product offerings by adding complimentary product lines, plugging holes in the current product offerings, or eliminating the operational or regulatory risks associated with R&D. M&A can also expand the end markets, geographic markets, and distribution channels. In the end, M&A should result in increased revenue at a specific cost and on a relatively short timeline. While growing product offerings, markets, and distribution channels can be accomplished organically, it generally takes more time and comes with a higher risk profile. Thus, M&A is effectively a one-stop solution for growth.
     
    Fenske: Are there special considerations to keep in mind when doing M&A in the medical device industry?
    Mattern: Integration and regulatory considerations are meaningful in medical device M&A. Integration considerations often require solutions for product and distribution channel overlap. Product overlap can result in cannibalization of an otherwise marketable product or may require a disposition of a valuable asset if there are antitrust concerns, each of which dilutes the benefit of the transaction. Distribution channel overlap may require moving from a distributor to a direct model, and/or revising sales territories, which could result in additional integration friction or costs. Generally integration considerations can be managed; however, the regulatory considerations can put the entire deal at risk or significantly alter the value proposition. Antitrust considerations can significantly delay deals and/or require certain assets to be sold (see Zimmer–Biomet deal). FDA considerations include the likelihood of the target’s product being approved and how to appropriately value when that risk exists (see Wright Medica–Biomimetic deal, and a host of pharma deals). Due to the global nature of most large medical device companies, FCPA risk must also be thoroughly vetted, otherwise you may have a significant impediment to consummation of the deal (see Abbott–Alere).
     
    Fenske: Is the window for using M&A for the inversion deal that Medtronic did with Covidien closed with the new regulations that were put into place after that transaction?
    Mattern: Inversion deals (acquiring a foreign company and redomesticating to the target company’s jurisdiction in order to recognize significant tax savings) are not dead, but they are severely wounded. Following the Medtronic–Covidien transaction, the Treasury department issued inversion regulations, which reduced the associated tax benefits and made it more difficult to effectuate. Those regulations effectively killed the AbbVie–Shire deal. Furthermore, the current political climate is very hostile to inversion deals. While on the campaign trail, President Trump labeled the Pfizer–Allergan deal and the related loss of jobs as “disgusting.” Secretary Clinton and Senator Sanders similarly blasted the deal. Thus, in the short-term, companies will be unlikely to utilize an inversion structure due to the loss of tax benefits and the likelihood of a very public reprisal.
     
    Fenske: What do you see in terms of non-traditional companies (e.g., tech companies) making acquisitions of medical device firms? Is that something you expect or will they simply continue to partner?
    Mattern: In 2016, there were several deals between tech companies and medical device or healthcare companies, including the Apple–Gliimpse, Nokia–Withings, and Logitech–Jaybird deals. Despite those deals, I think the vast majority of deals will continue to be partnerships or license arrangements. The cultural and operational differences between the sectors make those deals difficult to consummate. In contrast, licenses and partnerships tend to side-step those issues.
     
    Fenske: Where are we headed with regard to medtech M&A? What’s on the horizon in the next five to ten years?
    Mattern: I would expect continued consolidation. The fundamental drivers—access to capital, the ability to use M&A to expand the product offerings/extension of R&D without (or minimizing) the associated regulatory approval risk, and a generally supportive political environment—remain prevalent. However, I expect the pace to slow. Inversion deals, which fueled some of the prior M&A, won’t be a significant factor in the near term for reasons offered earlier. Furthermore, due to the prior consolidation, you have both a smaller pool of targets and, as a result, increased antitrust risk.
    Related Searches
    • cardiovascular
    • regulations
    • president
    • innovation
    Suggested For You
    How Can a Device End User Aid in Cybersecurity? How Can a Device End User Aid in Cybersecurity?
    What Could Medical Device Hacking’s Future Look Like? What Could Medical Device Hacking’s Future Look Like?
    Developing Leaders in the Workforce—MPO Videobites Developing Leaders in the Workforce—MPO Videobites
    Realizing the Value of Today’s Connected Worker—A Medtech Makers Q&A Realizing the Value of Today’s Connected Worker—A Medtech Makers Q&A
    Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development Seed Grants Awarded to Five Proposals for Pediatric Medical Device Development
    Real-World Medical Device Hacking Tales Real-World Medical Device Hacking Tales
    Nagarro Achieves ISO 13485 Certification Nagarro Achieves ISO 13485 Certification
    Mastering Motion for Robotic Surgical Systems—A Medtech Makers Q&A Mastering Motion for Robotic Surgical Systems—A Medtech Makers Q&A
    MICRO Expands with New Facility in Costa Rica MICRO Expands with New Facility in Costa Rica
    Glooko Raises $30 Million in Series D Funding Glooko Raises $30 Million in Series D Funding
    A Digital Stethoscope & Digital Health—A Medtech Matters Podcast A Digital Stethoscope & Digital Health—A Medtech Matters Podcast
    Three Future Trends and Opportunities in Quality Assurance Three Future Trends and Opportunities in Quality Assurance
    Adopting a Data-Driven Quality Model Adopting a Data-Driven Quality Model
    Viant Completes Expansion of Costa Rica Facility Viant Completes Expansion of Costa Rica Facility
    Digging into the Cardiac Arrhythmia Monitoring Device Market Digging into the Cardiac Arrhythmia Monitoring Device Market

    Related Online Exclusives

    • Electronics
      EMS

      EMS' Engineering Resources Increasingly in Demand

      Unpredictable demand, the need to reduce costs, and shorter production lead times driving companies to seek earlier interaction with product engineers.
      Michael Barbella, Managing Editor 04.20.21

    • Electronics
      Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

      Fiber Optics Introducing New Cleanliness Requirements for Medical Electronics

      Devices with high-speed data capabilities and high-resolution video must be rugged enough to withstand OR environment and harsh sterilization methods.
      Michael Barbella, Managing Editor 04.15.21

    • Electronics
      EMS Providers Valued for Product Customization, Medical Certification Expertise

      EMS Providers Valued for Product Customization, Medical Certification Expertise

      maxon has increased its service offering over the last few years and is collaborating closely with medtech firms for their electronics needs.
      Michael Barbella, Managing Editor 04.12.21


    • Software & IT
      Three Future Trends and Opportunities in Quality Assurance

      Three Future Trends and Opportunities in Quality Assurance

      As regulated companies, medical device firms must stay abreast of the latest developments to ensure they adopt new protocols to maintain quality assurance.
      David Jensen, Staff Writer, MasterControl 04.09.21

    • Software & IT
      Adopting a Data-Driven Quality Model

      Adopting a Data-Driven Quality Model

      Employing a data-driven quality model helps you apply quality processes more holistically throughout the organization.
      David Jensen, Staff Writer, MasterControl 04.09.21

    • Software & IT
      Digital Transformation for Quality and Manufacturing

      Digital Transformation for Quality and Manufacturing

      The pandemic has illustrated the importance of a transition to digital solutions for medical device and other life sciences manufacturers.
      Jon Beckstrand, CEO, MasterControl 04.08.21


    • Cardiovascular
      Digging into the Cardiac Arrhythmia Monitoring Device Market

      Digging into the Cardiac Arrhythmia Monitoring Device Market

      The overall market is set to reach an annual valuation of $9 billion by 2026.
      Saloni Walimbe, Research Content Developer, Global Market Insights 04.08.21

    • Cardiovascular
      Cardiovascular Device Market Expands to Tackle Higher Disease Burden

      Cardiovascular Device Market Expands to Tackle Higher Disease Burden

      The market is likely to exceed a valuation of $10 billion by 2027.
      Vinisha Joshi, Research Content Developer, Global Market Insights 04.01.21

    • Electronics
      Talented Labor Pool a Challenge for EMS Providers

      Talented Labor Pool a Challenge for EMS Providers

      Workers skilled in electrical wiring and installation in medical products can be difficult to find.
      Michael Barbella, Managing Editor 03.31.21


    • Diagnostics
      Diagnosing the IVD Market: An Interview with TEAM Technologies

      Diagnosing the IVD Market: An Interview with TEAM Technologies

      Chief revenue officer Steve Lents discusses the in-vitro diagnostic market and manufacturing rapid antigen POC COVID-19 tests.
      Sam Brusco, Associate Editor 03.30.21

    • Why Is Manufacturing Demand Increasing for IV Bags?

      Why Is Manufacturing Demand Increasing for IV Bags?

      Many types and sizes of IV bags are in short supply, putting a strain on the industry.
      Emily Newton, Editor-in-Chief, Revolutionized 03.30.21

    • Software & IT
      Using Quality as an Advantage in 2021

      Using Quality as an Advantage in 2021

      Report finds despite pandemic, 79 percent of medical device professionals expect modest or strong revenue growth in 2021.
      Jon Speer, Founder, Greenlight Guru 03.25.21


    • Software & IT
      5 Ways Manufacturers Can Improve IoMT Device Security

      5 Ways Manufacturers Can Improve IoMT Device Security

      Manufacturers cannot make development and security mistakes with IoMT devices.
      Emily Newton, Editor-in-Chief, Revolutionized 03.23.21

    • Software & IT
      Three Reasons Automation and Training Are Essential in Your MDQMS

      Three Reasons Automation and Training Are Essential in Your MDQMS

      Having the proper tools in place to ensure all training activities are occurring when and how they should is critical to quality.
      Jon Speer, Founder, Greenlight Guru 03.15.21

    • Four Ways Remote Freelance Experts Can Help Medtech

      Four Ways Remote Freelance Experts Can Help Medtech

      Changes in the regulatory landscape and working-from-home scenarios reduce the degree of change when working with remote consultants.
      Ramya Sriram, Digital Content Manager, Kolabtree 03.15.21


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Survey: Remote Patient Monitoring To Match Or Surpass In-Patient Within Five Years
    • Harnessing Critical Health Data With Wearable Technology
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Device Designed To Permanently Replace Failing Human Hearts
    Breaking News
    • FDA Grants 510(k) Clearance to LivaNova’s B-Capta
    • Gynesonics Appoints Susan Stimson to Its Board of Directors
    • Piezo Motion Debuts Piezoelectric Micro-Dosing Pump
    • Riva Health Raises $15.5 Million for Breakthrough Mobile Cardiology Technology
    • Abbott Begins Shipping Rapid COVID Self-Tests
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Longvida Curcumin Extract Receives ANVISA Approval in Brazil
    Curcugen Curcumin Formulation Evidenced to Attenuate Post-Exercise Inflammation
    Good Rāz Launches Taste-Free Vitamin D3 Drops
    Coatings World

    Latest Breaking News From Coatings World

    USGBC Releases Results of 2021 Green Building Community Survey
    PPG Publishes Sustainability Report
    Sherwin-Williams Launches Echelon
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA Grants 510(k) Clearance to LivaNova’s B-Capta
    Gynesonics Appoints Susan Stimson to Its Board of Directors
    Piezo Motion Debuts Piezoelectric Micro-Dosing Pump
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Evotec to Build Second Biologics Mfg. Facility in Toulouse
    Adare Pharma Names Ludger Roedder President of Adare Biome
    Johnson & Johnson 1Q Results
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Donginbi Launches Men’s Skincare Collection
    Kiehl’s Launches Pouch Refillables
    Skin Match Technology Partners with Men-Only Grooming Platforms
    Happi

    Latest Breaking News From Happi

    Robertet Appoints Reichert as Perfumer
    Kiehl’s Launches Sustainable Pouch Refillables for Hair Care, Skin Care
    New OTC Natural Hemp Pain Relief Gel Arrives at cbdMD
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PPG releases 2020 Sustainability Report
    GAA merges with AIMCAL
    Acucote expands Insights educational program
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Glatfelter GlatClean Nominated for World of Wipes Innovation Award
    P&G’s Sales Up 5%
    Ontex Tests Industrial Scale Diaper Composting
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    SeaSpine Begins Limited Rollout of WaveForm TO 3D-Printed Interbodies
    Spinal Elements' Lucent 3D Additive Manufactured Interbodies Earn FDA Nod
    Conformis, Paragon 28 Ink Licensing Deal
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI Appoints imec, Soitec Executives to Europe Advisory Board
    NREL Takes Novel Approach to 3D-Printed Water Power Prototypes
    Canatu Manufactures World’s Thinnest Free-standing CNB Membrane

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login